Mechanistic insights into influenza vaccine-associated narcolepsy

Human Vaccines and Immunotherapeutics

Volumn 12, Issue 12, 2016, Pages 3196-3201

  Ahmed, S Sohail ^a   Steinman, Lawrence ^b  

^a VisMederi Srl   (Italy)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adjuvants; adverse events; antibodies; autoimmunity; influenza; molecular mimicry; narcolepsy; pandemic; safety; vaccines

Indexed keywords

ADJUVANT; AUTOANTIBODY; G PROTEIN COUPLED RECEPTOR; HLA DQB1 ANTIGEN; INFLUENZA VACCINE; OREXIN 2 RECEPTOR; CORE PROTEIN; NP PROTEIN, INFLUENZA A VIRUS; OREXIN RECEPTOR; RNA BINDING PROTEIN; VIRUS ANTIBODY;

ANTIBODY RESPONSE; AUTOIMMUNITY; CANADA; CROSS REACTION; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; HUMAN; IMMUNOMODULATION; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MOLECULAR MIMICRY; NARCOLEPSY; NONHUMAN; NOTE; CHEMICALLY INDUCED; IMMUNOLOGY;

ANTIBODIES, VIRAL; CROSS REACTIONS; HUMANS; INFLUENZA VACCINES; NARCOLEPSY; OREXIN RECEPTORS; RNA-BINDING PROTEINS; VIRAL CORE PROTEINS;

EID: 85007496568     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2016.1171439     Document Type: Note

References (40)

1. Ahmed SS, Volkmuth W, Duca J, Corti L, Pallaoro M, Pezzicoli A, Karle A, Rigat F, Rappuoli R, Narasimhan V, et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med 2015; 7:294ra105; PMID:26136476
2. Jacob L, Leib R, Ollila HM, Bonvalet M, Adams CM, Mignot E. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain Behav Immun 2015; 47:44-57; PMID:25452148
3. Vaarala O, Vuorela A, Partinen M, Baumann M, Freitag TL, Meri S, Saavalainen P, Jauhiainen M, Soliymani R, Kirjavainen T, et al. Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines:Implications for Pandemrix-Associated Narcolepsy Risk. PLoS One 2014; 9:e114361; PMID:25501681; http://dx.doi.org/10.1371/journal.pone.0114361
4. van der Heide A, Verduijn W, Haasnoot GW, Drabbels JJ, Lammers GJ, Claas FH. HLA dosage effect in narcolepsy with cataplexy. Immunogenetics 2015; 67:1-6; PMID:25277311; http://dx.doi.org/10.1007/s00251-014-0808-z
5. de LL, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS, et al. The hypocretins:hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998; 95:322-7; PMID:9419374; http://dx.doi.org/10.1073/pnas.95.1.322
6. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, et al. Orexins and orexin receptors:a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92:573-85; PMID:9491897; http://dx.doi.org/10.1016/S0092-8674(00)80949-6
7. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355:39-40; PMID:10615891; http://dx.doi.org/10.1016/S0140-6736(99)05582-8
8. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6:991-7; PMID:10973318; http://dx.doi.org/10.1038/79690
9. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98:365-76; PMID:10458611; http://dx.doi.org/10.1016/S0092-8674(00)81965-0
10. Willie JT, Chemelli RM, Sinton CM, Tokita S, Williams SC, Kisanuki YY, Marcus JN, Lee C, Elmquist JK, Kohlmeier KA, et al. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice:molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 2003; 38:715-30; PMID:12797957; http://dx.doi.org/10.1016/S0896-6273(03)00330-1
11. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, et al. Narcolepsy in orexin knockout mice:molecular genetics of sleep regulation. Cell 1999; 98:437-51; PMID:10481909; http://dx.doi.org/10.1016/S0092-8674(00)81973-X
12. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001; 30:345-54; PMID:11394998; http://dx.doi.org/10.1016/S0896-6273(01)00293-8
13. Thompson MD, Comings DE, Abu-Ghazalah R, Jereseh Y, Lin L, Wade J, Sakurai T, Tokita S, Yoshida T, Tanaka H, et al. Variants of the orexin2/hcrt2 receptor gene identified in patients with excessive daytime sleepiness and patients with Tourette's syndrome comorbidity. Am J Med Genet B Neuropsychiatr Genet 2004; 129B:69-75; PMID:15274044; http://dx.doi.org/10.1002/ajmg.b.30047
14. EudraVigilance management system (DBMS). European Medicines Agency, 2015
15. Johansen K. The roles of influenza virus antigens and the AS03 adjuvant in the 2009 pandemic vaccine associated with narcolepsy needs further investigation. Dev Med Child Neurol 2014; 56:1041-2; PMID:25052448; http://dx.doi.org/10.1111/dmcn.12543
16. Ahmed SS, Schur PH, MacDonald NE, Steinman L. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations:what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun 2014; 50:1-11; PMID:24559657; http://dx.doi.org/10.1016/j.jaut.2014.01.033
17. Winstone AM, Stellitano L, Verity C, Andrews N, Miller E, Stowe J, Shneerson J. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol 2014; 56:1117-23; PMID:25041214; http://dx.doi.org/10.1111/dmcn.12522
18. Stowe J, Miller E, Andrews N, Kosky C, Leschziner G, Shneerson JM, Hall A, Eriksson S, Reading P, Dennis G, et al. Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults:A Case-Coverage Study in England. Sleep 2016; [Epub ahead of print] PMID:26856903
19. Tsai TF. MF59 adjuvanted seasonal and pandemic influenza vaccines. Yakugaku Zasshi 2011; 131:1733-41; PMID:22129867; http://dx.doi.org/10.1248/yakushi.131.1733
20. European Center for Disease P, Control. Enhanced Monitoring of Vaccine Safety for 2009 Pandemic Vaccines. 2013.
21. Montplaisir J, Petit D, Quinn MJ, Ouakki M, Deceuninck G, Desautels A, Mignot E, De WP. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One 2014; 9:e108489; PMID:25264897; http://dx.doi.org/10.1371/journal.pone.0108489
22. Hungs M, Fan J, Lin L, Lin X, Maki RA, Mignot E. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res 2001; 11:531-9; PMID:11282968; http://dx.doi.org/10.1101/gr.GR-1610R
23. Ahmed SS, Plotkin SA, Black S, Coffman RL. Assessing the safety of adjuvanted vaccines. Sci Transl Med 2011; 3:93rv2; PMID:21795590
24. Hampe CS. B Cell in Autoimmune Diseases. Scientifica (Cairo) 2012; 2012:1-18; http://dx.doi.org/10.6064/2012/215308
25. Bui HH, Sidney J, Dinh K, Southwood S, Newman MJ, Sette A. Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 2006; 7:153; PMID:16545123; http://dx.doi.org/10.1186/1471-2105-7-153
26. Tanaka S, Honda Y, Inoue Y, Honda M. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy:anti-Hcrt system antibody in narcolepsy. Sleep 2006; 29:633-8; PMID:16774153
27. Robertson N, Jazayeri A, Errey J, Baig A, Hurrell E, Zhukov A, Langmead CJ, Weir M, Marshall FH. The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery. Neuropharmacology 2011; 60:36-44; PMID:20624408; http://dx.doi.org/10.1016/j.neuropharm.2010.07.001
28. de Hoog HP, Lin JieRong EM, Banerjee S, Decaillot FM, Nallani M. Conformational antibody binding to a native, cell-free expressed GPCR in block copolymer membranes. PLoS One 2014; 9:e110847; PMID:25329156; http://dx.doi.org/10.1371/journal.pone.0110847
29. Ring AM, Manglik A, Kruse AC, Enos MD, Weis WI, Garcia KC, Kobilka BK. Adrenaline-activated structure of beta2-adrenoceptor stabilized by an engineered nanobody. Nature 2013; 502:575-9; PMID:24056936; http://dx.doi.org/10.1038/nature12572
30. Hislop JN, von Zastrow M. Analysis of GPCR localization and trafficking. Methods Mol Biol 2011; 746:425-40; PMID:21607873; http://dx.doi.org/10.1007/978-1-61779-126-0_25
31. Vincent A, Waters P, Leite MI, Jacobson L, Koneczny I, Cossins J, Beeson D. Antibodies identified by cell-based assays in myasthenia gravis and associated diseases. Ann NY Acad Sci 2012; 1274:92-8; PMID:23252902; http://dx.doi.org/10.1111/j.1749-6632.2012.06789.x
32. Han F, Lin L, Schormair B, Pizza F, Plazzi G, Ollila HM, Nevsimalova S, Jennum P, Knudsen S, Winkelmann J, et al. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Sleep 2014; 37:1601-8; PMID:25197808
33. Drakatos P, Leschziner G. Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin - an Explanation? J Clin Sleep Med 2015; 12(3):449-50
34. Tesoriero C, Codita A, Zhang MD, Cherninsky A, Karlsson H, Grassi-Zucconi G, Bertini G, Harkany T, Ljungberg K, Liljestrom P, et al. H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice. Proc Natl Acad Sci U S A 2016; 113:E368-77; PMID:26668381; http://dx.doi.org/10.1073/pnas.1521463112
35. Brask J, Chauhan A, Hill RH, Ljunggren HG, Kristensson K. Effects on synaptic activity in cultured hippocampal neurons by influenza A viral proteins. J Neurovirol 2005; 11:395-402; PMID:16162482; http://dx.doi.org/10.1080/13550280500186916
36. Thannickal TC, Siegel JM, Nienhuis R, Moore RY. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol 2003; 13:340-51; PMID:12946023; http://dx.doi.org/10.1111/j.1750-3639.2003.tb00033.x
37. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27:469-74; PMID:11055430; http://dx.doi.org/10.1016/S0896-6273(00)00058-1
38. Wu MF, Nienhuis R, Maidment N, Lam HA, Siegel JM. Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy. J Neurosci 2011; 31:6305-10; PMID:21525270; http://dx.doi.org/10.1523/JNEUROSCI.0365-11.2011
39. Yamanaka A, Tabuchi S, Tsunematsu T, Fukazawa Y, Tominaga M. Orexin directly excites orexin neurons through orexin 2 receptor. J Neurosci 2010; 30:12642-52; PMID:20861370; http://dx.doi.org/10.1523/JNEUROSCI.2120-10.2010
40. Valko PO, Gavrilov YV, Yamamoto M, Reddy H, Haybaeck J, Mignot E, Baumann CR, Scammell TE. Increase of histaminergic tuberomammillary neurons in narcolepsy. Ann Neurol 2013; 74:794-804; PMID:24006291; http://dx.doi.org/10.1002/ana.24019